Lifecycle management of orphan drugs approved in Japan

被引：0
|
作者：
Kiyoshi Seki
Hiroshi Suzuki
Seiji Abe
Chikako Saotome
机构：
[1] Kyoto University Graduate School of Medicine,
来源：
Orphanet Journal of Rare Diseases | / 17卷
关键词：
Orphan drug; Life cycle management; New indication approval; Patent; Re-examination term; Market exclusivity; Generics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Lifecycle management of orphan drugs approved in Japan
    Seki, Kiyoshi
    Suzuki, Hiroshi
    Abe, Seiji
    Saotome, Chikako
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [2] Development of Orphan Drugs in Japan: Characteristics of Orphan Drugs Developed in Japan
    Makoto Shiragami
    Kiyohito Nakai
    [J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 839 - 846
  • [3] Development of orphan drugs in Japan: Characteristics of orphan drugs developed in Japan
    Shiragami, M
    Nakai, K
    [J]. DRUG INFORMATION JOURNAL, 2000, 34 (03): : 839 - 846
  • [4] International comparison of availability for orphan drugs: focused on approved orphan drugs in South Korea
    Shin, Eun Young
    Hong, Young Jun
    Lim, Kyung Min
    Kim, Tae Hyang
    Lee, Jong Hyuk
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [5] Development of Orphan Drugs in Japan: Effects of a Support System for Development of Orphan Drugs in Japan
    Makoto Shiragami
    Kiyohito Nakai
    [J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 829 - 837
  • [6] Development of orphan drugs in Japan: Effects of a support system for development of orphan drugs in Japan
    Shiragami, M
    Nakai, K
    [J]. DRUG INFORMATION JOURNAL, 2000, 34 (03): : 829 - 837
  • [7] Pivotal Studies of Orphan Drugs Approved for Neurological Diseases
    Mitsumoto, Jun
    Dorsey, E. Ray
    Beck, Christopher A.
    Kieburtz, Karl
    Griggs, Robert C.
    [J]. ANNALS OF NEUROLOGY, 2009, 66 (02) : 184 - 190
  • [8] Publication trends associated with newly approved orphan drugs
    Woods, Catherine
    Kitchens, Elizabeth A.
    Zoog, Holly
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 : 25 - 25
  • [9] SHORTAGES OF DRUGS WITH APPROVED ORPHAN INDICATIONS IN THE UNITED STATES
    Felemban, D.
    Ghazawi, K.
    Alsheikh, M.
    Seoane-Vazquez, E.
    Rodriguez-Monguio, R.
    Fox, E. R.
    Szeinbach, S. L.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A23 - A23
  • [10] HEALTH ECONOMICS OF ORPHAN DRUGS IN JAPAN
    Zhang, M.
    Gulati, D.
    Duttagupta, S.
    Chalmers, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S55 - S55
12345